Drug delivery to the nasal cavity: in vitro and in vivo assessment.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Critical reviews in therapeutic drug carrier systems

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1615/CRITREVTHERDRUGCARRIERSYST.V21.I1.20PMID 15099184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations.

  2008cited by this paper
• Is nose‐to‐brain transport of drugs in man a reality?

  2004cited by this paper
• Validity of in Vitro Tests on Aqueous Spray Pumps as Surrogates for Nasal Deposition

  2004cited by this paper
• Gamma scintigraphy in the evaluation of pharmaceutical dosage forms

  2004cited by this paper
• Delivery of topical nasal drugs

  2003cited by this paper
• Absorption Enhancers for Nasal Drug Delivery

  2003cited by this paper
• P-Glycoprotein Attenuates Brain Uptake of Substrates After Nasal Instillation

  2003cited by this paper
• Nasal drug delivery--possibilities, problems and solutions.

  2003cited by this paper
• Preliminary Studies of the Pharmacokinetics and Tolerability of Zolmitriptan Nasal Spray in Healthy Volunteers

  2002cited by this paper
• A quantitative analysis of the intranasal delivery of topical nasal drugs to the middle meatus: spray versus drop administration

  2002cited by this paper
• Nasal drug delivery: new developments and strategies.

  2002cited by this paper
• Intranasal Immunization against Influenza

  2002cited by this paper
• Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation.

  2002cited by this paper
• Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides.

  2001cited by this paper
• Three-Dimensional Imaging of Aerosol Deposition

  2001cited by this paper
• Radionuclide Scanning, Respiratory Physiology, and Pharmacokinetics

  2001cited by this paper
• Microparticles for intranasal immunization.

  2001cited by this paper
• Effect of Variable Inspiratory Flow Rate on the Performance of the Budesonide Rhinocort Turbuhaler™

  2001cited by this paper
• Bioavailability and Bioequivalence: An FDA Regulatory Overview

  2001cited by this paper
• The effect of inferior turbinate hypertrophy on nasal spray distribution to the middle meatus.

  2001cited by this paper
• Intranasal toxicity of selected absorption enhancers.

  2001cited by this paper
• Clearance characteristics of chitosan based formulations in the sheep nasal cavity.

  2001cited by this paper
• Preliminary Study of the Deposition of Aerosol in the Maxillary Sinuses Using a Plastinated Model

  2001cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000cited by this paper
• The Effect of Nasal Patency on the Clearance of Radiolabeled Saline in Healthy Volunteers

  2000cited by this paper
• High uptake of 123I-metaiodobenzylguanidine related to olfactory neuroblastoma revealed by single-photon emission CT.

  2000cited by this paper
• Nuclear medicine imaging and drug delivery.

  2000cited by this paper
• Comparison of the clearance of radiolabelled nose drops and nasal spray as mucosally delivered vaccine.

  1999cited by this paper
• Deposition and Disposition of [11C]Zanamivir Following Administration as an Intranasal Spray

  1999cited by this paper
• Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder.

  1999cited by this paper
• Evaluation of the clearance characteristics of bioadhesive systems in humans.

  1999cited by this paper
• Comparison of Nasal Deposition and Clearance of Aerosol Generated by a Nebulizer and an Aqueous Spray Pump

  1999cited by this paper
• Cyclodextrins in nasal drug delivery.

  1999cited by this paper
• Biodistribution and kinetics of nasal carbon-11-triamcinolone acetonide.

  1998cited by this paper
• Alpha-1-antitrypsin labeling with technetium-99m for monitoring the deposition of alpha-1-antitrypsin in aerosol therapy.

  1998cited by this paper
• An endoscopic photographic comparison of nasal drug delivery by aqueous spray.

  1998cited by this paper
• The first attempt at radioisotopic evaluation of the integrity of the nose-brain barrier.

  1997cited by this paper
• New Opportunities in Molecular Imaging Using Pet

  1997cited by this paper
• Comparison between the effect of ipratropium bromide as a pressurized aerosol and as an aqueous pump spray on methacholine-induced rhinorrhoea.

  1996cited by this paper
• Accelerator mass spectrometry.

  1995cited by this paper
• Regional deposition of inhaled 11C‐nicotine vapor in the human airway as visualized by positron emission tomography

  1995cited by this paper
• Scintigraphic Assessment of the Oropharyngeal and Nasal Depositions of Fusafungine from a Pressurized Inhaler and from a Novel Pump Spray Device

  1995cited by this paper
• In vivo evaluation of dosage forms: application of gamma scintigraphy to non-enteral routes of administration.

  1994cited by this paper
• The Distribution of an Intranasal Insulin Formulation in Healthy Volunteers: Effect of Different Administration Techniques

  1994cited by this paper
• Background and Evolution of Endoscopic Sinus Surgery

  1994cited by this paper
• Nasal distribution of budesonide inhaled via a powder inhaler.

  1993cited by this paper
• Scintigraphic assessment of therapeutic aerosols.

  1993cited by this paper
• Review: clinical opportunities provided by the nasal administration of peptides.

  1993cited by this paper
• Di‐iodo‐l‐tyrosine‐labelled Dextrans as Molecular Size Markers of Nasal Absorption in the Rat

  1992cited by this paper
• The Nasal Mucociliary Clearance: Relevance to Nasal Drug Delivery

  1991cited by this paper
• A comparison between intranasal budesonide aerosol and budesonide dry powder in the treatment of hay fever symptoms.

  1991cited by this paper
• High speed photographic analysis of aerosols produced by metered dose inhalers

  1988cited by this paper
• Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin.

  1988cited by this paper
• A comparative distribution study of two procedures for administration of nose drops.

  1988cited by this paper
• The influence of solution viscosity on nasal spray deposition and clearance

  1988cited by this paper
• Deposition pattern of nasal sprays in man.

  1988cited by this paper
• The nasal distribution of metered does inhalers

  1987cited by this paper
• Allergic and Vasomotor Rhinitis - Clinical Aspects

  1987cited by this paper
• Bioadhesive microspheres as a potential nasal drug delivery system

  1987cited by this paper
• Deposition of particles in the human respiratory tract in the size range 0.005–15 μm

  1986cited by this paper
• A comparison of the regional deposition in a model nose of a drug discharged from metered aerosol and metered-pump nasal delivery systems.

  1986cited by this paper
• Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin.

  1986cited by this paper
• Intranasal drug delivery by spray and drops

  1985cited by this paper
• Distribution and clearance of radioactive aerosol on the nasal mucosa.

  1984cited by this paper
• Nasal sprays and polyps

  1984cited by this paper
• Video characterization of flume patterns of inhalation aerosols.

  1980cited by this paper
• Aerosol distribution in the nose.

  1978cited by this paper
• The upper airways. I. Nasal physiology and defense of the lungs.

  1977cited by this paper
• Distribution and removal of human serum albumin-technetium 99m instilled intranasally.

  1976cited by this paper
• The removal of particles from the nasopharyngeal (NP) compartment of the respiratory tract by nose blowing and swabbing.

  1975cited by this paper
• Clearance of inhaled particles from the human nose.

  1973cited by this paper

• Heavy Metals Environmental Fate in Metallurgical Solid Wastes: Occurrence, Leaching, and Ecological Risk Assessment

  2025influential citation
• The nasal route for nose-to-brain drug delivery: advanced nasal formulations for CNS disorders

  2025cites this paper
• Improved aerosol deposition predictions in human upper respiratory tract using coupled mesh phantom-based computational model

  2025cites this paper
• Characterizing regional drug delivery within the nasal airways

  2024cites this paper
• Optimization of formulation and device design for carrier-based nasal powder of influenza vaccine to maximize the delivery capability to the target site in the nasal cavity

  2024cites this paper
• Impact of amino acids on the properties of nasal dry powders

  2023cites this paper
• Establishing Quantitative Relationships between Changes in Nasal Spray In Vitro Metrics and Drug Delivery to the Posterior Nasal Region.

  2023cites this paper
• Facilitated Transport across Glycocalyceal Barriers in the Chick Chorioallantoic Membrane

  2023cites this paper
• Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic

  2022cites this paper
• Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review

  2022cites this paper
• Spray dried powders for nasal delivery: Process and formulation considerations.

  2022cites this paper
• Intranasal delivery of a synthetic Entamoeba histolytica vaccine containing adjuvant (LecA + GLA-3M-052 liposomes): in vitro characterization.

  2022cites this paper
• In Vitro Regional Deposition of Nasal Sprays in an Idealized Nasal Inlet: Comparison with In Vivo Gamma Scintigraphy

  2022cites this paper
• Effects of nasal anatomical characteristics and administration parameters on delivery of locally-acting drugs with suspension nasal sprays in adults

  2022cites this paper
• Comparison of Sinus Deposition from an Aqueous Nasal Spray and Pressurised MDI in a Post-Endoscopic Sinus Surgery Nasal Replica

  2022cites this paper
• Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease.

  2022cites this paper
• Importance of Spray–Wall Interaction and Post-Deposition Liquid Motion in the Transport and Delivery of Pharmaceutical Nasal Sprays

  2022cites this paper
• In Vitro Evaluation of Nasal Aerosol Depositions: An Insight for Direct Nose to Brain Drug Delivery

  2021cites this paper
• Nasal Route of Drug Delivery

  2021cites this paper
• A technology overview on advanced drug administration devices for effective nose-to-brain delivery

  2021cites this paper
• Preparation and characterization of halloysite nanotubes containing hydrogels for controlled release drug delivery of cetirizine dihydrochloride

  2021cites this paper
• Validating CFD predictions of nasal spray deposition: Inclusion of cloud motion effects for two spray pump designs

  2021cites this paper
• Determination of Spray Pattern and Plume Geometry of Combined Budesonide and Formoterol Fumarate pressurized Metered Dose Inhalation Aerosol

  2020cites this paper
• Factors influencing drug deposition in the nasal cavity upon delivery via nasal sprays

  2020cites this paper
• Nasal formulations for drug administration and characterization of nasal preparations in drug delivery.

  2020cites this paper
• Factors influencing drug deposition in the nasal cavity upon delivery via nasal sprays

  2020cites this paper
• In vitro Assessment of an Idealized Nose for Nasal Spray Testing: Comparison with Regional Deposition in Realistic Nasal Replicas.

  2020cites this paper
• In vitro - in vivo correlation of intranasal drug deposition.

  2020cites this paper
• In Vitro Evaluation of Regional Nasal Drug Delivery Using Multiple Anatomical Nasal Replicas of Adult Human Subjects and Two Nasal Sprays.

  2020cites this paper
• Nasal sprayed particle deposition in a human nasal cavity under different inhalation conditions

  2019cites this paper
• Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts.

  2018cites this paper
• Curcumin Cocrystal Micelles-Multifunctional Nanocomposites for Management of Neurodegenerative Ailments.

  2017cites this paper
• Pectins functionalized biomaterials; a new viable approach for biomedical applications: A review.

  2017cites this paper
• Alternate Routes of Administration

  2017cites this paper
• Developments in the formulation and delivery of spray dried vaccines

  2017cites this paper
• Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination

  2016cites this paper
• Nasal Administration of Vaccines

  2015cites this paper
• A New Pharmacoscintigraphic Technique for the Evalution of Pharmacokinetic Processes

  2015cites this paper
• Comparison of immune responses to intranasal and intrapulmonary vaccinations with the attenuated Mycoplasma hyopneumoniae 168 strain in pigs

  2015cites this paper
• Regional deposition of mometasone furoate nasal spray suspension in humans.

  2015cites this paper
• Design of Experiments to Optimize an In Vitro Cast to Predict Human Nasal Drug Deposition

  2014influential citation
• Nasal, Ocular and Otic Drug Delivery

  2014cites this paper
• A Comparison of the Deposition Patterns of Different Nasal Spray Formulations Using a Nasal Cast

  2014cites this paper
• Considerations for the Development of Nasal Dosage Forms

  2013influential citation
• Pulmonary and nasal deposition of ketorolac tromethamine solution (SPRIX) following intranasal administration.

  2012cites this paper
• In vivo imaging_Layout 1

  2012cites this paper
• In vivo imaging in drug development GAMMA SCINTIGRAPHY

  2012cites this paper
• Mucosal immunity and nasal influenza vaccination

  2012cites this paper
• Development of a novel model for comparative evaluation of intranasal pharmacokinetics and effects of anti-allergic nasal sprays.

  2012cites this paper
• Effects of Localized Hydrophilic Mannitol and Hydrophobic Nelfinavir Administration Targeted to Olfactory Epithelium on Brain Distribution

  2011cites this paper
• Enhanced Analgesic Responses After Preferential Delivery of Morphine and Fentanyl to the Olfactory Epithelium in Rats

  2011cites this paper
• Mucosal Targeting of a BoNT/A Subunit Vaccine Adjuvanted with a Mast Cell Activator Enhances Induction of BoNT/A Neutralizing Antibodies in Rabbits

  2011cites this paper
• Needle-free influenza vaccination.

  2010cites this paper
• Synthesis of biodegradable polymer-mesoporous silica composite microspheres for DNA prime-protein boost vaccination.

  2010cites this paper
• Novel Delivery Systems for Nasal Adminstration of Anthrax Vaccine

  2010cites this paper
• A Computational Fluid Dynamics Model for Drug Delivery in a Nasal Cavity with Inferior Turbinate Hypertrophy

  2010cites this paper
• Asian Journal of Pharmacodynamics and Pharmacokinetics

  2009cites this paper
• Recent research trends in intranasal therapeutics - Select case studies of various therapeutic strategies with pharmacokinetic/pharmacodynamic attributes and drug development considerations

  2009cites this paper
• Dry powder nasal vaccines as an alternative to needle-based delivery.

  2009cites this paper
• Calibration of the Andersen cascade impactor for the characterization of nasal products.

  2008cites this paper
• Dilute suspension flow with nanoparticle deposition in a representative nasal airway model

  2008cites this paper
• Process considerations related to the microencapsulation of plasmid DNA via ultrasonic atomization

  2008cites this paper
• Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities

  2008cites this paper
• Bioavailability of apomorphine hydrochloride released from a nasal spray in rabbits and rats

  2007cites this paper
• Nasal residence of insulin containing lyophilised nasal insert formulations, using gamma scintigraphy.

  2007cites this paper
• The development of stable influenza vaccine powder formulations for new needle-free dosage forms

  2007cites this paper
• Modeling of inertial particle transport and deposition in human nasal cavities with wall roughness

  2007cites this paper
• Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination

  2007cites this paper
• Development of stable influenza vaccine powder formulations for non-parenteral dosage forms: challenges and possibilities

  2007cites this paper
• The influence of actuation parameters on in vitro testing of nasal spray products.

  2006cites this paper
• Nasal delivery system for peptide drugs: market trend and technology development

  2006cites this paper
• Gamma Scintigraphy and SPECT

  2006cites this paper
• Analysis of Particle Deposition in the Turbinate and Olfactory Regions Using a Human Nasal Computational Fluid Dynamics Model

  2006cites this paper
• Validity of In Vitro Tests on Aqueous Spray Pumps as Surrogates for Nasal Deposition, Absorption, and Biologic Response

  2006cites this paper
• Divide or unite—a novel molecular switch in endometrial carcinoma

  2006cites this paper
• A Comparison of

  2006cites this paper
• Noninvasive delivery technologies: respiratory delivery of vaccines

  2006influential citation
• Expanding choices in intranasal steroid therapy: summary of a roundtable meeting.

  2006cites this paper
• Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy

  2006cites this paper
• A COMPARISON OF THE EFFICACY AND SAFETY OF INTRANASAL SUFENTANIL/MIDAZOLAM AND KETAMINE/MIDAZOLAM FOR SEDATION AND ANALGESIA IN A PAEDIATRIC POPULATION UNDERGOING MULTIPLE DENTAL EXTRACTIONS

  2005cites this paper
• In Vitro/In Vivo Correlations for Respiratory Drug Delivery

  2005cites this paper
• Sinonasal Distribution of Topically Applied Particles: Computerized Tomographic Detection and the Effects of Topical Decongestion

  2005influential citation
• Intranasal sufentanil/midazolam versus ketamine/midazolam for analgesia/sedation in the pediatric population prior to undergoing multiple dental extractions under general anesthesia: a prospective, double-blind, randomized comparison.

  2004cites this paper